Literature DB >> 22493093

Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver.

Santhosh Satapati1, Nishanth E Sunny, Blanka Kucejova, Xiaorong Fu, Tian Teng He, Andrés Méndez-Lucas, John M Shelton, Jose C Perales, Jeffrey D Browning, Shawn C Burgess.   

Abstract

The manner in which insulin resistance impinges on hepatic mitochondrial function is complex. Although liver insulin resistance is associated with respiratory dysfunction, the effect on fat oxidation remains controversial, and biosynthetic pathways that traverse mitochondria are actually increased. The tricarboxylic acid (TCA) cycle is the site of terminal fat oxidation, chief source of electrons for respiration, and a metabolic progenitor of gluconeogenesis. Therefore, we tested whether insulin resistance promotes hepatic TCA cycle flux in mice progressing to insulin resistance and fatty liver on a high-fat diet (HFD) for 32 weeks using standard biomolecular and in vivo (2)H/(13)C tracer methods. Relative mitochondrial content increased, but respiratory efficiency declined by 32 weeks of HFD. Fasting ketogenesis became unresponsive to feeding or insulin clamp, indicating blunted but constitutively active mitochondrial β-oxidation. Impaired insulin signaling was marked by elevated in vivo gluconeogenesis and anaplerotic and oxidative TCA cycle flux. The induction of TCA cycle function corresponded to the development of mitochondrial respiratory dysfunction, hepatic oxidative stress, and inflammation. Thus, the hepatic TCA cycle appears to enable mitochondrial dysfunction during insulin resistance by increasing electron deposition into an inefficient respiratory chain prone to reactive oxygen species production and by providing mitochondria-derived substrate for elevated gluconeogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22493093      PMCID: PMC3351815          DOI: 10.1194/jlr.M023382

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  67 in total

1.  Measurement of gluconeogenesis and pyruvate recycling in the rat liver: a simple analysis of glucose and glutamate isotopomers during metabolism of [1,2,3-(13)C3]propionate.

Authors:  J G Jones; R Naidoo; A D Sherry; F M Jeffrey; G L Cottam; C R Malloy
Journal:  FEBS Lett       Date:  1997-07-21       Impact factor: 4.124

Review 2.  NASH: a mitochondrial disease.

Authors:  Dominique Pessayre; Bernard Fromenty
Journal:  J Hepatol       Date:  2005-03-26       Impact factor: 25.083

3.  Steatohepatitis: a tale of two "hits"?

Authors:  C P Day; O F James
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

4.  Pseudoketogenesis in hepatectomized dogs.

Authors:  C Des Rosiers; J A Montgomery; M Garneau; F David; O A Mamer; P Daloze; G Toffolo; C Cobelli; B R Landau; H Brunengraber
Journal:  Am J Physiol       Date:  1990-03

5.  Noninvasive tracing of Krebs cycle metabolism in liver.

Authors:  I Magnusson; W C Schumann; G E Bartsch; V Chandramouli; K Kumaran; J Wahren; B R Landau
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

6.  Contributions of gluconeogenesis to glucose production in the fasted state.

Authors:  B R Landau; J Wahren; V Chandramouli; W C Schumann; K Ekberg; S C Kalhan
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

7.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

8.  Validation of two-pool model for in vivo ketone body kinetics.

Authors:  J W Bailey; M W Haymond; J M Miles
Journal:  Am J Physiol       Date:  1990-05

9.  14C-labeled propionate metabolism in vivo and estimates of hepatic gluconeogenesis relative to Krebs cycle flux.

Authors:  B R Landau; W C Schumann; V Chandramouli; I Magnusson; K Kumaran; J Wahren
Journal:  Am J Physiol       Date:  1993-10

10.  Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study.

Authors:  I Magnusson; D L Rothman; L D Katz; R G Shulman; G I Shulman
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

View more
  156 in total

1.  Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling.

Authors:  Kyle S McCommis; Zhouji Chen; Xiaorong Fu; William G McDonald; Jerry R Colca; Rolf F Kletzien; Shawn C Burgess; Brian N Finck
Journal:  Cell Metab       Date:  2015-09-03       Impact factor: 27.287

2.  Metabolic alterations in triptolide-induced acute hepatotoxicity.

Authors:  Jie Zhao; Cen Xie; Xiyan Mu; Kristopher W Krausz; Daxesh P Patel; Xiaowei Shi; Xiaoxia Gao; Qiao Wang; Frank J Gonzalez
Journal:  Biomed Chromatogr       Date:  2018-07-04       Impact factor: 1.902

3.  Integrated Regulation of Hepatic Lipid and Glucose Metabolism by Adipose Triacylglycerol Lipase and FoxO Proteins.

Authors:  Wenwei Zhang; So Young Bu; Mara T Mashek; InSug O-Sullivan; Zakaria Sibai; Salmaan A Khan; Olga Ilkayeva; Christopher B Newgard; Douglas G Mashek; Terry G Unterman
Journal:  Cell Rep       Date:  2016-03-31       Impact factor: 9.423

4.  Pigment epithelium-derived factor (PEDF) suppresses IL-1β-mediated c-Jun N-terminal kinase (JNK) activation to improve hepatocyte insulin signaling.

Authors:  Arijeet K Gattu; Andreas L Birkenfeld; Yasuko Iwakiri; Steven Jay; Mark Saltzman; Jennifer Doll; Petr Protiva; Varman T Samuel; Susan E Crawford; Chuhan Chung
Journal:  Endocrinology       Date:  2014-01-23       Impact factor: 4.736

5.  Aerobic capacity mediates susceptibility for the transition from steatosis to steatohepatitis.

Authors:  E Matthew Morris; Colin S McCoin; Julie A Allen; Michelle L Gastecki; Lauren G Koch; Steven L Britton; Justin A Fletcher; Xiarong Fu; Wen-Xing Ding; Shawn C Burgess; R Scott Rector; John P Thyfault
Journal:  J Physiol       Date:  2017-06-27       Impact factor: 5.182

6.  Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes.

Authors:  Robert A Egnatchik; Alexandra K Leamy; Yasushi Noguchi; Masakazu Shiota; Jamey D Young
Journal:  Metabolism       Date:  2013-10-24       Impact factor: 8.694

7.  Mice Carrying a Dominant-Negative Human PI3K Mutation Are Protected From Obesity and Hepatic Steatosis but Not Diabetes.

Authors:  Marie H Solheim; Jonathon N Winnay; Thiago M Batista; Anders Molven; Pål R Njølstad; C Ronald Kahn
Journal:  Diabetes       Date:  2018-05-03       Impact factor: 9.461

8.  Nutrient sensing by the mitochondrial transcription machinery dictates oxidative phosphorylation.

Authors:  Lijun Liu; Minwoo Nam; Wei Fan; Thomas E Akie; David C Hoaglin; Guangping Gao; John F Keaney; Marcus P Cooper
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

9.  Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.

Authors:  Santhosh Satapati; Blanka Kucejova; Joao A G Duarte; Justin A Fletcher; Lacy Reynolds; Nishanth E Sunny; Tianteng He; L Arya Nair; Kenneth A Livingston; Kenneth Livingston; Xiaorong Fu; Matthew E Merritt; A Dean Sherry; Craig R Malloy; John M Shelton; Jennifer Lambert; Elizabeth J Parks; Ian Corbin; Mark A Magnuson; Jeffrey D Browning; Shawn C Burgess
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

10.  Improved hepatic lipid composition following short-term exercise in nonalcoholic fatty liver disease.

Authors:  Jacob M Haus; Thomas P J Solomon; Karen R Kelly; Ciaran E Fealy; Emily L Kullman; Amanda R Scelsi; Lan Lu; Mangesh R Pagadala; Arthur J McCullough; Chris A Flask; John P Kirwan
Journal:  J Clin Endocrinol Metab       Date:  2013-04-24       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.